Impact of educational interventions on adverse drug events reporting

Página do item simplificado
dc.contributor.authorPagotto, Caroline [UNESP]
dc.contributor.authorVarallo, Fabiana
dc.contributor.authorMastroianni, Patrícia
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2015-12-07T15:30:24Z
dc.date.available2015-12-07T15:30:24Z
dc.date.issued2013
dc.description.abstractSpontaneous adverse drug events (ADE) reporting is the main source of data for assessing the risk/benefit of drugs available in the pharmaceutical market. However, its major limitation is underreporting, which hinders and delays the signal detection by Pharmacovigilance (PhV). To identify the techniques of educational intervention (EI) for promotion of PhV by health professionals and to assess their impact. A systematic review was performed in the PUBMED, PAHO, LILACS and EMBASE databases, from November/2011 to January/2012, updated in March/2013. The strategy search included the use of health descriptors and a manual search in the references cited by selected papers. 101 articles were identified, of which 16 met the inclusion criteria. Most of these studies (10) were conducted in European hospitals and physicians were the health professionals subjected to most EI (12), these studies lasted from one month to two years. EI with multifaceted techniques raised the absolute number, the rate of reporting related to adverse drug reactions (ADR), technical defects of health technologies, and also promoted an improvement in the quality of reports, since there was increased reporting of ADR classified as serious, unexpected, related to new drugs and with high degree of causality. Multifaceted educational interventions for multidisciplinary health teams working at all healthcare levels, with sufficient duration to reach all professionals who act in the institution, including issues related to medication errors and therapeutic ineffectiveness, must be validated, with the aim of standardizing the Good Practice of PhV and improve drug safety indicators.en
dc.description.affiliationDrugs and Medicines, School of Pharmaceutical Sciences of the Universidade Estadual Paulista Júlio de Mesquita Filho-Unesp.
dc.description.affiliationUnespDrugs and Medicines, School of Pharmaceutical Sciences of the Universidade Estadual Paulista Júlio de Mesquita Filho-Unesp.
dc.format.extent410-417
dc.identifierhttp://dx.doi.org/10.1017/S0266462313000457
dc.identifier.citationInternational Journal Of Technology Assessment In Health Care, v. 29, n. 4, p. 410-417, 2013.
dc.identifier.doi10.1017/S0266462313000457
dc.identifier.issn1471-6348
dc.identifier.lattes4160558780902988
dc.identifier.orcid0000-0001-8467-7278
dc.identifier.pubmed24290334
dc.identifier.urihttp://hdl.handle.net/11449/130955
dc.language.isoeng
dc.publisherInternational Journal Of Technology Assessment In Health Care
dc.relation.ispartofInternational Journal Of Technology Assessment In Health Care
dc.relation.ispartofsjr0,714
dc.rights.accessRightsAcesso restrito
dc.sourcePubMed
dc.subjectPharmacovigilanceen
dc.subjectAdverse drug reaction reporting systemsen
dc.subjectEducation continuingen
dc.subjectEducational interventionen
dc.subjectHealth knowledgeen
dc.subjectAttitudesen
dc.subjectPracticeen
dc.titleImpact of educational interventions on adverse drug events reportingen
dc.typeArtigo
unesp.author.lattes4160558780902988[3]
unesp.author.orcid0000-0001-8467-7278[3]
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Ciências Farmacêuticas, Araraquarapt

Arquivos

Coleções

Artigos - Fármacos e Medicamentos - FCFAR